Impact of hepatic steatosis on treatment response in nuclesos(t)ide analogue-treated HBeAg-positive chronic hepatitis B: a retrospective study.
Yi-Cheng ChenWen-Juei JengChao-Wei HsuChun-Yen LinPublished in: BMC gastroenterology (2020)
HS had no significant impact on HBeAg seroclearance in HBeAg-positive CHB patients with NA monotherapy during long-term follow-up.